The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
9 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,096,437 in first-year total cost, median $616,667.
Most frequent study sections
- Cancer Biomarkers Study Section[CBSS]9
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL2
- UNIVERSITY OF TX MD ANDERSON CAN CTR2
- BECKMAN RESEARCH INSTITUTE/CITY OF HOPE1
- BETH ISRAEL DEACONESS MEDICAL CENTER1
- CEDARS-SINAI MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | Standardized Molecular Analyses of Glioma EVs1R01CA237500-01A1 | CARTER, BOB SLEE, HAKHO | MASSACHUSETTS GENERAL HOSPITAL, MA | $649,034 | CBSS |
| 2020 | Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN)1R01CA237332-01A1 | WEISSLEDER, MD, PHD, RALPH | MASSACHUSETTS GENERAL HOSPITAL, MA | $384,300 | CBSS |
| 2019 | Rigorous and reproducible mutational analysis of the urinary exosomal DNA1R01CA231465-01A1 | DINNEY, COLIN P.N.KALLURI, RAGHU | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $616,667 | CBSS |
| 2019 | Exosomal Biomarkers for the Noninvasive Detection of Colorectal Cancer1R01CA227602-01A1 | GOEL, AJAY | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $501,433 | CBSS |
| 2018 | Effect of methodological and biological variability on molecular profiling of extracellular vesicles in cancer detection1R01CA218500-01A1 | GHIRAN, IONITA CALINIVANOV, ALEXANDER R. | NORTHEASTERN UNIVERSITY, MA | $677,886 | CBSS |
| 2018 | Isolation and Assessment of Blood-Circulating Cancer Exosomes with LSS and SERS Lab on a Chip Optical Spectroscopic Instrument1R01CA218382-01A1 | PERELMAN, LEV T | BETH ISRAEL DEACONESS MEDICAL CENTER, MA | $668,549 | CBSS |
| 2018 | Longitudinal therapeutic monitoring of colorectal cancer patients using exosome-based liquid biopsies1R01CA218230-01A1 | KOPETZ, SCOTTMAITRA, ANIRBAN | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | $663,998 | CBSS |
| 2017 | Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model1R01CA218513-01 | LYDEN, DAVID CHARLESZHANG, HAIYING | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $472,052 | CBSS |
| 2017 | High-throughput palmitoyl-proteomics profiling of extracellular vesicles for identification of biomarkers for early detection of clinically significant prostate cancer1R01CA218526-01 | DI VIZIO, DOLORESYANG, WEIZIJLSTRA, ANDRIES | CEDARS-SINAI MEDICAL CENTER, CA | $462,518 | CBSS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.